| Literature DB >> 17496998 |
Abstract
The organosilicon derivatives of 2-[1-(2-furayl)ethyledene]sulphathiazole with organosilicon chlorides have been synthesised and characterized on the basis of analytical, conductance, and spectroscopic techniques. Probable trigonal bipyramidal and octahedral structures for the resulting derivatives have been proposed on the basis of electronic, IR, (1)H, (13)C NMR, and (29)Si NMR spectral studies. In the search for better fungicides, bactericides, nematicides, and insecticides studies were conducted to assess the growth-inhibiting potential of the synthesized complexes against various pathogenic fungal, bacterial strains, root-knot nematode Meloidogyne incognita, and insect Trogoderma granarium. These studies demonstrate that the concentrations reached levels which are sufficient to inhibit and kill the pathogens, nematode, and insect.Entities:
Year: 2006 PMID: 17496998 PMCID: PMC1686292 DOI: 10.1155/BCA/2006/13743
Source DB: PubMed Journal: Bioinorg Chem Appl Impact factor: 7.778
Scheme 1Analysis and physical properties of the ligand and its silicon complexes.
| Compound | Elemental analysis (%) | ||||||||||||
|
| |||||||||||||
| Reactant (g) | Colour | Yield | MP |
|
|
|
|
|
| Mol Wt | |||
| M | LH | Na | and state | (%) | (°C) | Found | Found | Found | Found | Found | Found | Found | |
| (Calcd) | (Calcd) | (Calcd) | (Calcd) | (Calcd) | (Calcd) | (Calcd) | |||||||
|
| |||||||||||||
| (2-Ac-F-StH) | — | — | — | Light yellow | 73 | 124–130 | 51.62 | 3.51 | 11.84 | 18.19 | — | — | 325 |
| (51.86) | (3.77) | (12.09) | (18.45) | (347.39) | |||||||||
|
| 0.38 | 1.02 | 0.07 | Dark brown | 74 | 71–73 | 46.18 | 3.88 | 9.26 | 14.19 | 6.07 | 8.00 | 412 |
| solid | (46.40) | (4.12) | (9.55) | (14.57) | (6.38) | (8.05) | (439.99) | ||||||
|
| 0.11 | 0.61 | 0.04 | Light brown | 76 | 109–111 | 50.99 | 3.67 | 10.77 | 16.70 | 3.48 | — | 738 |
| solid | (51.18) | (4.02) | (11.19) | (17.07) | (3.74) | (750.92) | |||||||
|
| 0.48 | 0.66 | 0.04 | Dark brown | 74 | 149–151 | 57.15 | 3.58 | 7.09 | 11.00 | 4.71 | 5.92 | 542 |
| solid | (57.48) | (3.93) | (7.44) | (11.36) | (4.97) | (6.28) | (564.13) | ||||||
|
| 0.29 | 0.81 | 0.05 | Dark brown | 77 | 155–157 | 57.31 | 3.74 | 9.42 | 14.19 | 3.00 | — | 858 |
| solid | (57.64) | (3.91) | (9.60) | (14.65) | (3.20) | (875.05) | |||||||
|
| 0.51 | 0.60 | 0.04 | Brown solid | 81 | 90–92 | 65.02 | 4.12 | 6.68 | 10.19 | 4.22 | — | 588 |
| (65.42) | (4.49) | (6.93) | (10.58) | (4.63) | (605.78) | ||||||||
*M = silicon compound, LH = ligand, and Na = sodium metal.
Scheme 2General equations showing the formations of the sodium salt and the complexes (R = Me and Ph).
UV spectral data of the ligand and its silicon complexes.
| Ligand/complex |
|
|
|
| >C=N |
| >C=N | |
|
| |||
| (2-Ac-F-StH) | 370 | 255 | 285 |
|
| 359 | 273 | 281 |
|
| 362 | 276 | 278 |
|
| 351 | 280 | 275 |
|
| 355 | 285 | 271 |
|
| 353 | 290 | 268 |
IR spectral data (cm−1) of the ligand and its silicon complexes.
| Compound/ligand |
|
|
|
|
|
| ||||
|
| 3400-3150 (m) | 1628 (vs) | — | — |
|
| — | 1622 | 577 w | 423 m |
|
| — | 1625 | 582 w | — |
|
| — | 1619 | 574 w | 439 m |
|
| — | 1613 | 576 w | — |
|
| — | 1616 | 570 w | — |
*m = medium, vs = very strong, and w = weak.
NMR spectral data (δ, ppm) of the ligand and its silicon complexes.
| Ligand/complex |
|
|
| Aromatic proton |
|
|
| |||||
|
| — | 2.10 (3H, s | 10.54 (br | 8.10-6.92 (m) | — |
|
| 1.01 (1s, 6H) | 2.25 (3H, s) | — | 8.36-7.20 (m) | −98 (ppm) |
|
| 1.13 (s, 6H) | 2.17 (6H, s) | — | 8.784-7.00 (m) | −128 (ppm) |
|
| — | 2.22 (3H, s) | — | 8.48-6.95 (m) | −94 (ppm) |
|
| — | 2.15 (6H, s) | — | 8.56-7.30 (m) | −110 (ppm) |
|
| — | 2.19 (3H, s) | — | 8.51-7.14 (m) | −91 (ppm) |
*m = multiplet, br = broad, and s = singlet.
NMR spectral data (δ, ppm) of the ligand and its silicon complexes.
| Ligand/complex | Azomethine C-atom |
|
|
|
|
|
| C11 |
|
|
|
|
|
| ||||
|
| ||||||||
|
| 155.91 | — | 146.02 | 138.99 | 120.98 | 143.94 | 152.60 | 151.80 |
| 128.01 | 122.46 | 124.01 | 125.98 | 150.00 | ||||
|
| 144.76 | 13.98 | 148.91 | 139.21 | 121.12 | 142.92 | 149.20 | 150.70 |
| 125.96 | 120.24 | 123.67 | 119.76 | 150.95 | ||||
|
| 148.51 | 15.01 | 147.69 | 140.96 | 121.32 | 143.01 | 149.45 | 149.85 |
| 124.21 | 120.96 | 122.21 | 119.10 | 151.00 | ||||
|
| 153.46 | — | 146.36 | 137.01 | 120.76 | 142.10 | 151.20 | 149.70 |
| 126.01 | 121.78 | 119.98 | 122.46 | 150.15 | ||||
|
| 146.76 | — | 145.16 | 138.06 | 127.92 | 143.21 | 147.20 | 150.12 |
| 128.96 | 121.02 | 120.21 | 123.74 | 149.80 | ||||
|
| 154.90 | — | 144.05 | 133.42 | 120.81 | 143.40 | 148.78 | 149.40 |
| 127.01 | 121.98 | 123.32 | 124.86 | 150.55 | ||||
Figure 1(a) The penta-coordinated trigonal bipyramidal and (b) hexa-coordinated octahedral geometries R = Me/Ph and X = Ph/Cl.
Fungicidal screening data of the ligand and its silicon complexes inhibition percentage after 96 hours and SD values (25, 50, and 100 are concentrations in ppm).
| Ligand/complex |
|
|
|
| ||||||||
|
| ||||||||||||
| 25 | 50 | 100 | 25 | 50 | 100 | 25 | 50 | 100 | 25 | 50 | 100 | |
|
| ||||||||||||
|
| 34 | 53 | 61 | 35 | 50 | 68 | 39 | 56 | 65 | 43 | 60 | 66 |
| (50.72) | (38.37) | (37.75) | (51.38) | (39.02) | (29.16) | (44.28) | (38.46) | (35.00) | (39.44) | (30.23) | (34.00) | |
|
| ||||||||||||
|
| 37 | 56 | 72 | 38 | 52 | 71 | 42 | 59 | 71 | 45 | 62 | 68 |
| (46.37) | (34.88) | (36.11) | (47.22) | (36.58) | (26.04) | (40.00) | (35.16) | (29.00) | (36.62) | (27.91) | (32) | |
|
| ||||||||||||
|
| 42 | 63 | 78 | 41 | 57 | 74 | 46 | 65 | 74 | 47 | 65 | 72 |
| (39.13) | (26.74) | (20.40) | (43.05) | (30.48) | (22.44) | (35.28) | (28.57) | (26.00) | (33.80) | (24.42) | (28.00) | |
|
| ||||||||||||
|
| 38 | 57 | 76 | 40 | 53 | 72 | 43 | 61 | 73 | 46 | 63 | 70 |
| (44.92) | (33.72) | (22.44) | (44.44) | (35.36) | (26.53) | (38.57) | (32.96) | (27.00) | (35.21) | (26.74) | (30.00) | |
|
| ||||||||||||
|
| 44 | 66 | 82 | 47 | 61 | 80 | 48 | 67 | 78 | 49 | 66 | 76 |
| (36.23) | (23.25) | (16.32) | (34.72) | (25.60) | (18.36) | (31.42) | (26.37) | (22.00) | (30.99) | (23.26) | (24.00) | |
|
| ||||||||||||
|
| 40 | 60 | 80 | 42 | 54 | 73 | 45 | 63 | 75 | 47 | 64 | 71 |
| (42.02) | (30.23) | (18.36) | (41.66) | (34.14) | (25.51) | (35.71) | (30.76) | (25.00) | (33.80) | (25.58) | (29.00) | |
|
| ||||||||||||
| Bavistin | 69 | 86 | 98 | 72 | 82 | 96 | 70 | 91 | 100 | 71 | 86 | 100 |
Adulticidal screening data of the ligand and its silicon complexes (100 and 200 are concentrations in ppm).
| Ligand/complex | Dose level | Average no. of | Average mortality | % adult | % corrected | |
| adults in each vial | after 48 hours | mortality | mortality | |||
|
| ||||||
|
| 100 | 20 | 4 | 20 | 15.78 | |
| 200 | 20 | 6 | 30 | 26.31 | ||
|
| 100 | 20 | 7 | 35 | 31.57 | |
| 200 | 20 | 11 | 55 | 52.63 | ||
|
| 100 | 20 | 11 | 55 | 52.63 | |
| 200 | 20 | 14 | 70 | 68.42 | ||
|
| 100 | 20 | 9 | 45 | 42.10 | |
| 200 | 20 | 12 | 60 | 57.10 | ||
|
| 100 | 20 | 12 | 60 | 57.89 | |
| 200 | 20 | 15 | 75 | 57.89 | ||
|
| 100 | 20 | 10 | 50 | 73.68 | |
| 200 | 20 | 4 | 70 | 47.36 | ||
| Control | — | 20 | 1 | 5 | 68.42 | |
Ovicidal screening data of the ligand and its silicon complexes (100 and 200 are concentrations in ppm).
| Ligand/complex | Dose level | Average no. of | Average no. of | % eggs | % eggs | % corrected |
| eggs hatched | eggs unhatched | hatching | unhatched | mortality | ||
|
| ||||||
|
| 100 | 15 | 5 | 75 | 25 | 21.05 |
| 200 | 11 | 9 | 55 | 45 | 42.10 | |
|
| 100 | 13 | 7 | 65 | 35 | 31.57 |
| 200 | 9 | 11 | 45 | 55 | 52.63 | |
|
| 100 | 9 | 11 | 45 | 55 | 52.63 |
| 200 | 7 | 13 | 35 | 65 | 63.15 | |
|
| 100 | 11 | 9 | 55 | 45 | 42.10 |
| 200 | 7 | 13 | 35 | 65 | 63.15 | |
|
| 100 | 8 | 12 | 40 | 60 | 57.89 |
| 200 | 5 | 15 | 25 | 75 | 73.68 | |
|
| 100 | 10 | 10 | 50 | 50 | 47.36 |
| 200 | 7 | 13 | 35 | 65 | 63.15 | |
| Control | — | 19 | 1 | 95 | 5 | — |
Larvicidal screening data of the ligand and its silicon complexes (100 and 200 are concentrations in ppm).
| Ligand/complex | Dose level | Average no. of | Average no. of | % pupal | % larval | % corrected |
| pupal formed | dead larvae | formation | mortality | mortality | ||
|
| ||||||
|
| 100 | 16 | 4 | 80 | 20 | 15.78 |
| 200 | 13 | 7 | 65 | 35 | 31.57 | |
|
| 100 | 13 | 7 | 65 | 35 | 31.57 |
| 200 | 10 | 10 | 50 | 50 | 47.36 | |
|
| 100 | 9 | 11 | 45 | 55 | 52.63 |
| 200 | 7 | 13 | 35 | 65 | 63.15 | |
|
| 100 | 11 | 9 | 55 | 45 | 42.10 |
| 200 | 8 | 12 | 40 | 60 | 57.89 | |
|
| 100 | 7 | 13 | 35 | 65 | 63.15 |
| 200 | 5 | 15 | 25 | 75 | 73.68 | |
|
| 100 | 11 | 9 | 55 | 45 | 42.10 |
| 200 | 6 | 14 | 30 | 70 | 68.42 | |
| Control | — | 19 | 1 | 95 | 5 | — |
Pupicidal screening data of the ligand and its silicon complexes (100 and 200 are concentrations in ppm).
| Ligand/complex | Dose level | Average no. of | Average no. of | % emerged | % pupal | % corrected |
| adults emerged | pupal mortality | adult | mortality | mortality | ||
|
| ||||||
|
| 100 | 15 | 5 | 75 | 25 | 21.05 |
| 200 | 14 | 6 | 70 | 30 | 26.31 | |
|
| 100 | 14 | 6 | 70 | 30 | 26.31 |
| 200 | 11 | 9 | 55 | 45 | 42.10 | |
|
| 100 | 10 | 10 | 50 | 50 | 47.36 |
| 200 | 6 | 14 | 30 | 70 | 68.42 | |
|
| 100 | 12 | 8 | 60 | 40 | 38.84 |
| 200 | 8 | 12 | 40 | 60 | 57.89 | |
|
| 100 | 9 | 11 | 45 | 55 | 52.63 |
| 200 | 5 | 15 | 25 | 75 | 73.68 | |
|
| 100 | 11 | 9 | 55 | 45 | 42.10 |
| 200 | 7 | 13 | 35 | 65 | 63.15 | |
| Control | — | 19 | 1 | 95 | 5 | — |
Bactericidal screening data of the ligand and its silicon complexes diameter inhibition zone (mm) after 24 hours (500 and 1000 are concentrations in ppm).
| Ligand/complex |
|
|
|
| ||||
|
| ||||||||
| 500 | 1000 | 500 | 1000 | 500 | 1000 | 500 | 1000 | |
|
| ||||||||
| (2-Ac-F-StH) | 6 | 6 | 6 | 11 | 10 | 12 | 9 | 13 |
|
| 8 | 12 | 9 | 15 | 12 | 14 | 12 | 14 |
|
| 10 | 16 | 11 | 17 | 15 | 17 | 16 | 18 |
|
| 10 | 14 | 10 | 16 | 14 | 16 | 15 | 16 |
|
| 13 | 18 | 14 | 19 | 17 | 19 | 18 | 19 |
|
| 11 | 16 | 12 | 17 | 15 | 17 | 16 | 17 |
| Streptomycin | 1 | 2 | 3 | 5 | 2 | 5 | 15 | 17 |
Nematicidal screening data of the ligand and its silicon complexes (25, 50, and 100 are concentrations in ppm).
| Ligand/complex | (% of hatching | ||
|
| |||
| 25 | 50 | 100 | |
|
| |||
|
| 22.5 | 19.0 | 15.0 |
|
| 20.2 | 16.5 | No hatching |
|
| 18.5 | 14.9 | No hatching |
|
| 19.6 | 16.4 | No hatching |
|
| 15.9 | 11.9 | No hatching |
|
| 18.6 | 14.0 | No hatching |